Miami Cancer Institute

Baptist Health Miami Cancer Institute Names Firas El Chaer, M.D., MSHCM, Chief of Leukemia and Medical Director of Infusion Services

March 18, 2025

MIAMI, FL – March 18, 2025 – Board-certified hematologist-oncologist Firas El Chaer, M.D., MSHCM, has been named chief of Leukemia and medical director of Infusion Services at Baptist Health Miami Cancer Institute. He specializes in the treatment of leukemia, with a primary focus on acute myeloid leukemia, acute lymphoblastic leukemia, chronic myelomonocytic leukemia and chronic myeloid leukemia. His expertise also extends to myeloproliferative neoplasms, clonal hematopoiesis of indeterminate potential as well as bone marrow failure disorders, including myelodysplastic syndromes and aplastic anemia.

Dr. El Chaer utilizes personalized, targeted therapies to enhance treatment effectiveness and improve patient responses. Additionally, he has a keen interest in measurable residual disease detection and monitoring, which can improve patients’ long-term outcomes and survival rates by catching early signs of relapse and adjusting treatments accordingly.

Prior to joining Baptist Health, Dr. El Chaer was an associate professor of medicine in the Division of Hematology-Oncology at the University of Virginia School of Medicine. He also served as medical director of the Cancer Service Line – Infusion Centers and medical director of the Chronic and Acute Leukemia Research Team at the University of Virginia Comprehensive Cancer Center.

"We are pleased to welcome Dr. El Chaer to our highly skilled team of cancer care specialists, dedicated to providing the highest quality care,” said Leonard Kalman, M.D., executive deputy medical director and chief medical officer at Miami Cancer Institute.

Dr. El Chaer earned his medical degree at the University of Balamand in Beirut, Lebanon. He served as chief resident during an internal medicine residency at the Icahn School of Medicine at Mount Sinai in Englewood, N.J. He then completed a fellowship in infectious diseases for immune-compromised cancer patients at the combined program of Baylor College of Medicine and the University of Texas at MD Anderson Cancer Center in Houston. He also completed a fellowship in hematology and oncology with a focus on blood disorders and a built-in fellowship in stem cell transplantation at the University of Maryland School of Medicine in Baltimore, where he served as chief fellow. Dr. El Chaer is board certified by the American Board of Internal Medicine in internal medicine, infectious diseases, hematology and medical oncology.

In addition to his patient care responsibilities, Dr. El Chaer is a clinical investigator and principal investigator for numerous pharmaceutical-sponsored clinical trials and investigator-initiated trials. He has been recognized with multiple awards across different areas of professional practice, including his clinical skills, research contributions and teaching abilities. One such award is the prestigious Arnold P. Gold Foundation Humanism in Medicine Award, which honors mentors who demonstrate care and compassion in the teaching and advising of medical students.

Dr. El Chaer is an active member of numerous professional organizations. He also contributes to the scientific community by presenting his research findings at national and international symposiums, editing and reviewing papers for medical publications and publishing his research in peer-reviewed journals, with more than 50 articles appearing in prominent journals such as Blood and JAMA Oncology.

Dr. El Chaer’s approach to patient care is deeply rooted in his personal experience, having witnessed the profound impact of non-Hodgkin lymphoma on his father and family. He prioritizes clear, compassionate communication and strives to connect with his patients and their families on a personal level, not only addressing medical needs but also serving as a supportive guide through each step of the cancer journey. “My goal is to provide care that is as personal as it is professional, creating a support system that goes beyond traditional treatment,” Dr. El Chaer said.

Dr. El Chaer is fluent in English, French and Arabic. He will see patients at Miami Cancer Institute, located at 8900 North Kendall Drive, Miami, FL 33176.

About Baptist Health 
Baptist Health is the largest healthcare organization in the region, with 12 hospitals, more than 28,000 employees, 4,000 physicians and 200 outpatient centers, urgent care facilities and physician practices spanning across Miami-Dade, Monroe, Broward and Palm Beach counties. Baptist Health has internationally renowned institutes specializing in cancer care, brain and spine care, heart and vascular care and orthopedic care. In addition, it includes Baptist Health Medical Group; Baptist Health Quality Network; and The Baptist Health PineApp, a virtual health platform. Baptist Health South Florida is an academic and clinical affiliate of Florida International University Herbert Wertheim College of Medicine. A not-for-profit organization supported by philanthropy and committed to its faith-based charitable mission of medical excellence, Baptist Health has been recognized by Fortune as one of the 100 Best Companies to Work For in America and is the most awarded healthcare system in South Florida by U.S. News and World Report. For more information, visit 
BaptistHealth.net/Newsroom and connect with us on FacebookX (formerly Twitter), InstagramTikTok and LinkedIn.

 

XXX

Language Preference / Preferencia de idioma

I want to see the site in English

Continue In English

Quiero ver el sitio en Español

Continuar en español